Fact CheckerSign in

NCT07435688Completed

Comparison of the Effectiveness of Mirror Therapy and Mirror Mode of Hand Robot in Stroke

Comparison of The Effectiveness Of Mirror Therapy And Mirror Mode of a Hand Robot in Upper Extremity Motor Recovery After Stroke

Source: ClinicalTrials.gov · Last updated 15 Apr 2026

Brief summary (registry, in English)

The goal of this clinical trial is to compare the effectiveness of conventional mirror therapy and robotic mirror mode training in promoting upper extremity motor recovery in adult patients with ischemic stroke during the early subacute phase. The main questions it aims to answer are: Does mirror mode of a robotic hand device result in greater motor function recovery compared to conventional mirror therapy? Are there differences between the groups in somatosensory improvement and gross motor skill outcomes? Do both intervention modalities result in clinically significant improvements in motor and functional outcomes? Researchers will compare a conventional mirror therapy group and a robotic-assisted mirror mode group to determine which provides more significant gains in motor function, somatosensory input, and functional use of the paretic arm. Participants will: Receive standard physiotherapy sessions for 6 weeks Be randomly assigned to either mirror therapy or robotic mirror mode intervention Be evaluated using Fugl-Meyer Assessment, ARAT, Box and Block Test, Wolf Motor Function Test and Tactile/proprioceptive sensory test using Fugl-Meyer Assessment Sensory subsection.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
18 Jun 2025
Start date
10 Jan 2024
Primary completion date
25 Nov 2024
Lead sponsor
Zeynep Lide Uz
Diseases
Stroke
NCT number
NCT07435688

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 10 Jan 2024 to the primary completion date, 25 Nov 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Severe Pain (VAS ≥ 8)
  • Having a neurological or orthopedic problem in hand
  • Severe spatial hemineglect (NIHSS 11th subscale\> 1)
  • Spasticity (mAS ≥ 2)
  • Apraxia
  • Visual/auditory loss that affects treatment
  • Unstable Vital Signs

Who the study is looking for

  • Having a ischemic/hemorrhagic stroke diagnosis through MRI and/or CT
  • Volunteering to enter the study
  • First ever stroke or no sequeale (mRS 0)
  • Being in subacute/chronic phase of stroke (between 1st week to 1 year)
  • Having a adequate sitting balance or able to maintain upright sitting position for 30 minutes
  • Having a motor deficit in the hand (Brunnstrom hand motor recovery stages 1-4 )
  • Having a full range of motion in hand

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alkent 2000, 34500 Büyükçekmece/İstanbul
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status
İstanbul University-Cerrahpaşa
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.